Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medicine, University of the Ryukyus, Nishihara, Okinawa, Japan.
Department of Otorhinolaryngology, Head and Neck Surgery, Asahi University Hospital, Mizuho, Gifu, Japan.
Auris Nasus Larynx. 2022 Aug;49(4):680-689. doi: 10.1016/j.anl.2021.11.010. Epub 2021 Dec 9.
The localization pattern of metastatic sentinel lymph node (SN) and non-SNs and pathologic analysis of metastatic lymph nodes in SN lymphatic basin dissection (SLBD) were investigated in patients with cT2/T3cN0 oral squamous cell carcinoma (OSCC).
This prospective multicenter trial involved 10 institutions nationwide in Japan. A total of 57 patients were enrolled. The lateral neck was divided into 5 lymphatic basins. The lymphatic basin containing SNs was defined as the SN lymphatic basin. All patients underwent SLBD with backup selective neck dissection (I-III) combined with primary tumor removal. When SNs were found outside of levels I-III, including in the contralateral neck, SLBD was performed by removing the compartments containing SNs separately. SN metastasis was classified as isolated tumor cells (ITCs), micrometastasis, or macrometastasis. ITCs are defined as a lesion no larger than 0.2 mm in largest dimension and are classified as pN0.
SN metastasis was observed in 22 cases. All metastatic lymph nodes, including false-negative cases, were detected in the SN lymphatic basin. Isolated tumor cells in the SNs did not affect prognosis, whereas micrometastasis tended to have poor prognosis. After adjusting for other risk factors, a positive SN remained a significant predictor of poor 5-year overall survival in pT2-4 OSCC.
SLBD for intraoperative SN biopsy is a sufficient therapeutic procedure and is valuable for determining pathologic nodal stage in OSCC. SN positivity was demonstrated to be an independent predictor of poor prognosis in patients with pT2-4 disease undergoing SLBD with backup selective neck dissection (I-III).
研究 cT2/T3cN0 口腔鳞状细胞癌(OSCC)患者转移性前哨淋巴结(SN)和非-SN 的定位模式以及 SN 淋巴结清扫术(SLBD)中转移性淋巴结的病理分析。
本前瞻性多中心试验涉及日本全国 10 个机构。共有 57 名患者入组。将侧颈部分为 5 个淋巴结区。包含 SN 的淋巴结区定义为 SN 淋巴结区。所有患者均接受 SLBD 联合原发灶切除术,伴或不伴选择性颈清扫术(I-III 区)。当 SN 位于 I-III 区以外,包括对侧颈部时,通过分别切除包含 SN 的隔室来进行 SLBD。SN 转移分为孤立肿瘤细胞(ITCs)、微转移和宏转移。ITC 定义为最大直径不超过 0.2mm 的病变,分类为 pN0。
22 例患者出现 SN 转移。所有包括假阴性病例的转移性淋巴结均在 SN 淋巴结区被检出。SN 中的 ITCs 不影响预后,而微转移倾向于预后不良。在调整其他危险因素后,SN 阳性仍然是 pT2-4 OSCC 患者 5 年总生存率的显著预后不良预测因素。
术中 SN 活检的 SLBD 是一种充分的治疗程序,对确定 OSCC 的病理淋巴结分期具有重要价值。SN 阳性被证明是接受 SLBD 联合选择性颈清扫术(I-III 区)的 pT2-4 疾病患者预后不良的独立预测因素。